J0641 Levoleucovorin - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Levoleucovorin

Brand Name:

Fusilev

Levoleucovorin

Strength:

0.5 mg

HCPCS:

J0641

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Chemoprotective

Minor Drug Class:

Antidote

Oral (Y/N):

No

FDA Approval Year:

2008

FDA Discontinuation Year:

CMS Effective Date:

Oct. 1, 2019

CMS Discontinuation Date:

Status:

In Use